696 related articles for article (PubMed ID: 1317690)
1. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
Peterson ME; Kemppainen RJ; Orth DN
Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
[TBL] [Abstract][Full Text] [Related]
2. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
[TBL] [Abstract][Full Text] [Related]
3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
4. Plasma profiles of adrenocorticotropic hormone, cortisol, alpha-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy.
Hanson JM; Kooistra HS; Mol JA; Teske E; Meij BP
J Endocrinol; 2006 Sep; 190(3):601-9. PubMed ID: 17003261
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone: stimulation of ACTH secretion in normal man.
DeBold C; Orth DN; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Island DP
Horm Metab Res Suppl; 1987; 16():8-16. PubMed ID: 2832299
[TBL] [Abstract][Full Text] [Related]
6. Pituitary-adrenal function in dogs with acute critical illness.
Martin LG; Groman RP; Fletcher DJ; Behrend EN; Kemppainen RJ; Moser VR; Hickey KC
J Am Vet Med Assoc; 2008 Jul; 233(1):87-95. PubMed ID: 18593315
[TBL] [Abstract][Full Text] [Related]
7. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
[TBL] [Abstract][Full Text] [Related]
8. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs.
Moore GE; Hoenig M
Am J Vet Res; 1992 May; 53(5):716-20. PubMed ID: 1326243
[TBL] [Abstract][Full Text] [Related]
9. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
[TBL] [Abstract][Full Text] [Related]
10. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs.
Feldman EC
J Am Vet Med Assoc; 1981 Apr; 178(8):823-6. PubMed ID: 6268586
[TBL] [Abstract][Full Text] [Related]
11. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency.
Schulte HM; Chrousos GP; Avgerinos P; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1064-7. PubMed ID: 6327750
[TBL] [Abstract][Full Text] [Related]
12. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum.
Okamoto E; Takagi T; Makino T; Sata H; Iwata I; Nishino E; Mitsuda N; Sugita N; Otsuki Y; Tanizawa O
Horm Metab Res; 1989 Oct; 21(10):566-72. PubMed ID: 2553573
[TBL] [Abstract][Full Text] [Related]
14. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y
J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
[TBL] [Abstract][Full Text] [Related]
15. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of ovine and human CRH.
Schürmeyer TH; Schulte HM; Avgerinos PC; Tomai TP; Loriaux DL; Gold PW; Chrousos GP
Horm Metab Res Suppl; 1987; 16():24-30. PubMed ID: 2832286
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment clinical and laboratory findings in dogs with hypoadrenocorticism: 225 cases (1979-1993).
Peterson ME; Kintzer PP; Kass PH
J Am Vet Med Assoc; 1996 Jan; 208(1):85-91. PubMed ID: 8682712
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of plasma aldosterone concentrations before and after ACTH administration in clinically normal dogs and in dogs with various diseases.
Willard MD; Refsal K; Thacker E
Am J Vet Res; 1987 Dec; 48(12):1713-8. PubMed ID: 2829668
[TBL] [Abstract][Full Text] [Related]
20. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
